Almirall SA
MAD:ALM

Watchlist Manager
Almirall SA Logo
Almirall SA
MAD:ALM
Watchlist
Price: 8.47 EUR 2.11% Market Closed
Market Cap: 1.8B EUR
Have any thoughts about
Almirall SA?
Write Note

Intrinsic Value

The intrinsic value of one ALM stock under the Base Case scenario is 11.31 EUR. Compared to the current market price of 8.47 EUR, Almirall SA is Undervalued by 25%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ALM Intrinsic Value
11.31 EUR
Undervaluation 25%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Almirall SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ALM cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ALM?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Almirall SA

Provide an overview of the primary business activities
of Almirall SA.

What unique competitive advantages
does Almirall SA hold over its rivals?

What risks and challenges
does Almirall SA face in the near future?

Summarize the latest earnings call
of Almirall SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Almirall SA.

Provide P/S
for Almirall SA.

Provide P/E
for Almirall SA.

Provide P/OCF
for Almirall SA.

Provide P/FCFE
for Almirall SA.

Provide P/B
for Almirall SA.

Provide EV/S
for Almirall SA.

Provide EV/GP
for Almirall SA.

Provide EV/EBITDA
for Almirall SA.

Provide EV/EBIT
for Almirall SA.

Provide EV/OCF
for Almirall SA.

Provide EV/FCFF
for Almirall SA.

Provide EV/IC
for Almirall SA.

Show me price targets
for Almirall SA made by professional analysts.

What are the Revenue projections
for Almirall SA?

How accurate were the past Revenue estimates
for Almirall SA?

What are the Net Income projections
for Almirall SA?

How accurate were the past Net Income estimates
for Almirall SA?

What are the EPS projections
for Almirall SA?

How accurate were the past EPS estimates
for Almirall SA?

What are the EBIT projections
for Almirall SA?

How accurate were the past EBIT estimates
for Almirall SA?

Compare the revenue forecasts
for Almirall SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Almirall SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Almirall SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Almirall SA compared to its peers.

Compare the P/E ratios
of Almirall SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Almirall SA with its peers.

Analyze the financial leverage
of Almirall SA compared to its main competitors.

Show all profitability ratios
for Almirall SA.

Provide ROE
for Almirall SA.

Provide ROA
for Almirall SA.

Provide ROIC
for Almirall SA.

Provide ROCE
for Almirall SA.

Provide Gross Margin
for Almirall SA.

Provide Operating Margin
for Almirall SA.

Provide Net Margin
for Almirall SA.

Provide FCF Margin
for Almirall SA.

Show all solvency ratios
for Almirall SA.

Provide D/E Ratio
for Almirall SA.

Provide D/A Ratio
for Almirall SA.

Provide Interest Coverage Ratio
for Almirall SA.

Provide Altman Z-Score Ratio
for Almirall SA.

Provide Quick Ratio
for Almirall SA.

Provide Current Ratio
for Almirall SA.

Provide Cash Ratio
for Almirall SA.

What is the historical Revenue growth
over the last 5 years for Almirall SA?

What is the historical Net Income growth
over the last 5 years for Almirall SA?

What is the current Free Cash Flow
of Almirall SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Almirall SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Almirall SA

Current Assets 704.4m
Cash & Short-Term Investments 343.1m
Receivables 147.2m
Other Current Assets 214.1m
Non-Current Assets 1.6B
Long-Term Investments 16.6m
PP&E 143.9m
Intangibles 1.3B
Other Non-Current Assets 178.6m
Current Liabilities 270.3m
Other Current Liabilities 270.3m
Non-Current Liabilities 568.9m
Long-Term Debt 346.7m
Other Non-Current Liabilities 222.2m
Efficiency

Earnings Waterfall
Almirall SA

Revenue
1.4B EUR
Cost of Revenue
-386m EUR
Gross Profit
1B EUR
Operating Expenses
-958.7m EUR
Operating Income
58.7m EUR
Other Expenses
-94.6m EUR
Net Income
-35.9m EUR

Free Cash Flow Analysis
Almirall SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Almirall's Q1 2024 showed a robust 7% net sales growth, driven mainly by the European Dermatology business, which saw an 18% increase. Products like Ilumetri, Klisyri, and Wynzora significantly contributed to this momentum. Notably, Ilumetri, a biologic for psoriasis, grew by 30% to EUR 49 million. The company also launched Ebglyss in Germany, achieving EUR 3.6 million in sales and high initial market acceptance. Despite a slight decline in U.S. sales due to a cyberattack, the company expects to accelerate growth with upcoming launches. R&D investments grew by 10%, focusing on pipeline assets for long-term growth. The company reaffirmed its full-year guidance, expecting gross margins to remain close to the 2023 level.

What is Earnings Call?
Fundamental Scores

ALM Profitability Score
Profitability Due Diligence

Almirall SA's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional ROIC
ROIC is Increasing
Positive Revenue Growth Forecast
53/100
Profitability
Score

Almirall SA's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

ALM Solvency Score
Solvency Due Diligence

Almirall SA's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
56/100
Solvency
Score

Almirall SA's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALM Price Targets Summary
Almirall SA

Wall Street analysts forecast ALM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALM is 12.06 EUR with a low forecast of 9.89 EUR and a high forecast of 16.45 EUR.

Lowest
Price Target
9.89 EUR
17% Upside
Average
Price Target
12.06 EUR
42% Upside
Highest
Price Target
16.45 EUR
94% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ALM?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ALM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Almirall SA Logo
Almirall SA

Country

Spain

Industry

Pharmaceuticals

Market Cap

1.8B EUR

Dividend Yield

1.76%

Description

Almirall SA is a global biopharmaceutical company, which is focused on skin health. The company is headquartered in Barcelona, Barcelona and currently employs 1,785 full-time employees. The company went IPO on 2007-04-19. The firm focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The firm's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The firm operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.

Contact

BARCELONA
Barcelona
Ronda General Mitre, 151
+34932913000.0
www.almirall.es

IPO

2007-04-19

Employees

1 785

Officers

CEO, President, Member of Management Board & Chairman of the Board
Mr. Carlos Gallardo Piqué
CFO & Member of Management Board
Mr. Michael McClellan
Chief Industrial Operations Officer & Member of Management Board
Mr. Eloi Crespo Cervera
Chief People & Culture Officer and Member of Management Board
Mr. Esteve Conesa Panicot
Chief Medical Officer & Member of Management Board
Dr. Volker Koscielny
Chief Scientific Officer & Member of Management Board
Dr. Karl Ziegelbauer
Show More
Chief Commercial Officer Europe & International and Member of Management Board
Mr. Paolo Cionini
Company Vice Secretary,Chief Legal Officer, General Counsel & Member of Management Board
Ms. Isabel Cristina Gomes
Chief Marketing Officer & Member of Management Board
Ms. Mercedes Diz Lopez
Show Less

See Also

Discover More
What is the Intrinsic Value of one ALM stock?

The intrinsic value of one ALM stock under the Base Case scenario is 11.31 EUR.

Is ALM stock undervalued or overvalued?

Compared to the current market price of 8.47 EUR, Almirall SA is Undervalued by 25%.

Back to Top